Menu Back to Quantitative-Science-Forum-for-Pharmaceutical-Product-Development

Program Committee

  • Qin  Huang, PhD
    Qin Huang, PhD Deputy Director, Office of Biostatistics Center For Drug Evaluation, CFDA, China
  • William  Wang, PhD
    William Wang, PhD Executive Director, Clinical Safety & Risk Management Statistics Merck Research Laboratories, Merck & Co., Inc., China
  • Bingming  Yi
    Bingming Yi Director GSK, China
  • Chen  YAO
    Chen YAO Associate Director Peking University Clinical Research Institute, China
  • Daniel  Liu, PhD
    Daniel Liu, PhD Chief Scientific Officer Beijing Clinical Service Center, China
  • Feng  Chen, PhD
    Feng Chen, PhD Professor, Dean School of Public Health, Nanjing Medical University, China
  • Jacqueline  Law, PhD
    Jacqueline Law, PhD Roche, China
  • Jie  Chen, PhD
    Jie Chen, PhD Director, Global Biostatistics Merck Serono (Beijing) Pharmaceutical R&D Co. Ltd., China
  • Huaqiong  SHEN, MD, PhD
    Huaqiong SHEN, MD, PhD Chief Medical Officer Jiangsu Hengrui Medicine Co., Ltd., China
  • Joanne  Liu, MD, MBA
    Joanne Liu, MD, MBA Director, Asia Pacific, Global Data Management & Standard MSD R&D (China) Co., Ltd. , China
  • Roger (Peng)  Qu, PhD
    Roger (Peng) Qu, PhD Head of Clinical Statistics Pfizer China R&D Center, China
  • Wei  Zhang
    Wei Zhang Regional Head of Biometrics and Data Management, Asia/MENA Boehringer Ingelheim Shanghai Pharmaceuticals Co., Ltd., China
  • Weiying  Yuan, PhD
    Weiying Yuan, PhD Site Head of Biostatistics & Programming Johnson & Johnson, China
  • Yanping  Wang
    Yanping Wang Director Lilly, China
  • Yazhong  Deng, MBA
    Yazhong Deng, MBA Director, Clinical Data, Analysis and Reporting organization Covance Pharmaceutical Research and Development (Beijing) Co., Ltd., China
Load More